Immuno-chemotherapy with a combination of rituximab, methotrexate, pirarubicin and procarbazine for patients with primary CNS lymphoma - A preliminary report [2]

Leukemia and Lymphoma

Volumn 48, Issue 5, 2007, Pages 1019-1022

  Yamanaka, Ryuya ^a,b   Homma, Junpei ^a   Sano, Masakazu ^a   Tsuchiya, Naoto ^a   Yajima, Naoki ^a   Shinbo, Yoshikatsu ^c   Hasegawa, Akira ^d   Onda, Kiyoshi ^a   Tanaka, Ryuichi ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Itoigawa General Hospital   (Japan)

^d Niigata Kobari Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ELECTROLYTE; ETOPOSIDE; FOLINIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOGLOBIN; LACTATE DEHYDROGENASE; METHOTREXATE; PIRARUBICIN; PREDNISONE; PROCARBAZINE; RITUXIMAB; UREA;

ADULT; AGED; ANEMIA; BLOOD TOXICITY; BONE MARROW SUPPRESSION; BRAIN RADIATION; CANCER IMMUNOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARDIOTOXICITY; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CYTOLOGY; DEEP VEIN THROMBOSIS; DIGESTIVE SYSTEM DISEASE; DRUG EFFICACY; DRUG FATALITY; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; ELECTROLYTE BLOOD LEVEL; FEMALE; HEMOGLOBIN DETERMINATION; HISTOPATHOLOGY; HUMAN; INFECTION; INTERSTITIAL PNEUMONIA; LACTATE DEHYDROGENASE BLOOD LEVEL; LETTER; LEUKOCYTE COUNT; LEUKOPENIA; LIVER FUNCTION TEST; LIVER TOXICITY; LOW DRUG DOSE; LUMBAR PUNCTURE; LUNG TOXICITY; MALE; MOUTH INFECTION; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT RESPONSE; TUMOR VOLUME; UREA BLOOD LEVEL;

AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CENTRAL NERVOUS SYSTEM NEOPLASMS; COMBINED MODALITY THERAPY; DOXORUBICIN; FEMALE; HUMANS; IMMUNOTHERAPY; LYMPHOMA; MALE; METHOTREXATE; MIDDLE AGED; PILOT PROJECTS; PROCARBAZINE;

EID: 34547455185     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701248009     Document Type: Letter

References (15)

1. DeAngelis, L. M., Yahalom, J., Thaler, H. T. and Kher, U. (1992) Combined modality therapy for primary CNS lymphoma. J Clin Oncol, 10, pp. 635-643.
2. Bessell, E. M., Graus, F., Punt, J. A., Firth, J. L., Hope, D. T. and Moloney, A. J. (1996) Primary non-Hodgkin's lymphoma of the CNS treated with BVAM or CHOD/BVAM chemotherapy before radiotherapy. J Clin Oncol, 14, pp. 945-954.
3. Yamanaka, R. and Tanaka, R. (2004) Advances for the treatment of primary central nervous system lymphoma (review). Oncol Rep, 12, pp. 563-568.
4. Abrey, L. E., DeAngelis, L. M. and Yahalom, J. (1998) Long-term survival in primary CNS lymphoma. J Clin Oncol, 16, pp. 859-863.
5. Abrey, L. E., Yahalom, J. and DeAngelis, L. M. (2000) Treatment for primary CNS lymphoma: The next step. J Clin Oncol, 18, pp. 3144-3150.
6. Freilich, R. J., Delattre, J. Y., Monjour, A. and DeAngelis, L. M. (1996) Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients. Neurology, 46, pp. 435-439.
7. Yamanaka, R., Morii, K., Shinbo, Y., Takeuchi, S., Tamura, T. and Hondoh, H. (2005) Modified ProMACE-MOPP hybrid regimen with moderate dose methotrexate for patients with primary CNS lymphoma. Ann Hematol, 84, pp. 447-455.
8. Aoki, S., Tsukada, N., Nomoto, N., Maruyama, S., Takahashi, M. and Moriyama, Y. (1998) Effect of pirarubicin for elderly patients with malignant lymphoma. J Exp Clin Cancer Res, 17, pp. 465-470.
9. Enting, R. H., Demopoulos, A., DeAngelis, L. M. and Abrey, L. E. (2004) Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide. Neurology, 63, pp. 901-903.
10. O'Brien, P., Roos, D., Pratt, G., Liew, K., Barton, M. and Poulsen, M. (2000) Phase II multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphoma. J Clin Oncol, 18, pp. 519-526.
11. Sandor, V., Stark-Vancs, V., Pearson, D., Nussenblat, R., Whitcup, S. M. and Brouwers, P. (1998) Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma. J Clin Oncol, 16, pp. 3000-3006.
12. Schlegel, U., Pels, H., Glasmacher, A., Kleinschmidt, R., Schmidt-Wolf, I. and Helmstaedter, C. (2001) Combined systemic and intraventricular chemotherapy in primary CNS lymphoma: A pilot study. J Neurol Neurosurg Psychiatry, 71, pp. 118-122.
13. Neuwelt, E. A., Goldman, D. L., Dahlborg, S. A., Crossen, J., Ramsey, F. and Roman-Goldstein, S. (1991) Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: Prolonged survival and preservation of cognitive function. J Clin Oncol, 9, pp. 1580-1590.
14. Pels, H., Schmidt-Wolf, I. G., Glasmacher, A., Schulz, H., Engert, A. and Diehl, V. (2003) Primary central nervous system lymphoma: Results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy. J Clin Oncol, 21, pp. 4489-4495.
15. Cher, L., Glass, J., Harsh, G. R. and Hochberg, F. H. (1996) Therapy of primary CNS lymphoma with methotrexate-based chemotherapy and deferred radiotherapy: Preliminary results. Neurology, 46, pp. 1757-1759.